Drug Profile
R 803
Alternative Names: R-803Latest Information Update: 16 Jun 2005
Price :
$50
*
At a glance
- Originator Rigel Pharmaceuticals
- Class Antivirals
- Mechanism of Action Hepatitis C virus NS 5 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis C